Substance / Medication

Abciximab

Overview

Active Ingredient
abciximab
RxNorm CUI
83929

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Intra-arterial versus intravenous abciximab therapy for thromboembolic complications of neuroendovascular procedures: case review and meta-analysis.
Kansagra Akash P, McEachern James D, Madaelil Thomas P et al. · J Neurointerv Surg · 2017
PMID: 27540089Meta-Analysis
Intracoronary abciximab reduces death and major adverse cardiovascular events in acute coronary syndromes: a meta-analysis of clinical trials.
De Rosa Salvatore, Caiazzo Gianluca, Torella Daniele et al. · Int J Cardiol · 2013
PMID: 23273690Meta-Analysis
A review of intracoronary abciximab in percutaneous coronary interventions--where are we now and where do we go from here?
Sharma Sanjiv, Bhalla Kumud, Singh Sarabjeet · Recent Pat Cardiovasc Drug Discov · 2013
PMID: 23957238Meta-Analysis
Updated evidence on intracoronary abciximab in ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials.
Kubica Jacek, Koziński Marek, Navarese Eliano P et al. · Cardiol J · 2012
PMID: 22641541Meta-Analysis
Intracoronary versus intravenous abciximab administration in STEMI patients: overview of current status and open questions.
Kubica Aldona, Kozinski Marek, Navarese Eliano Pio et al. · Curr Med Res Opin · 2011
PMID: 21942506Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Abciximab (substance)
SNOMED CT
386951001
UMLS CUI
C0288672
RxNorm CUI
83929

Clinical Data

This intervention maps to 2 entities in the Healos knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.